Up 400% in 5 years: Can Nearmap Ltd repeat the trick?

Up 400% in 5 years: Can Nearmap Ltd repeat the trick?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

First of all in writing this article I'd like to acknowledge former Fool Mike King who passed away from cancer late last year and encouraged myself and others to buy Nearmap shares many years ago. Mike was a brilliant investor, but more importantly a kind man who gave up a lot of time to share his knowledge with younger investors and in particular his enthusiasm for the Nearmap business…..Thanks, Mike.

Nearmap is an aerial imagery company that sells its images to the local government sector (planners, civil agencies, etc) solar panel industry, construction sector, roofers, and landscape gardeners among others in the pubic and private sectors.

Over the past five years its share price is up nearly 5x (or 400%) from 35 cents to $1.74 today, but thinking you've 'missed the boat' on this company's march higher may be an expensive mistake.

Let's take a look at seven quick reasons why this stock could go higher.

  • Competitive position – Historically this has been considered Nearmap's Achilles Heel, with the likes of Google Maps, drones and satellites all potentially disrupting its aerial imagery business model in quick time. Admittedly disruption remains a risk, but it should be noted that Nearmap's growing data set and unique technology (3D + oblique imagery) give it a moderate competitive advantage in the specialist sector in which it operates.
  • Attractive business model –  Nearmap is a software-as-a-service (SaaS) business and boasts the attractive economic traits of recurring revenues, relatively fixed operating costs, and high gross profit margins. This means profits should grow faster than revenues if the business develops to plan.
  • Growth – you're not going to get a growing share price anywhere without growth and in FY 2018 Nearmap grew its annualised contract value (ACV) 41% to $66.2 million, with a two-year compound growth rate of 35%. Moreover, thanks to its expansion into the U.S, revenue growth is now accelerating under its sales-driven boss Patrick Quigley. It goes without saying that the U.S. market alone is a massive opportunity.
  • Balance sheet – The group has a cash balance of $17.5 million and posted a cash outflow of $3.2 million for the six months ending June 30, 2018. It expects to reach cash flow break even this financial year. In effect cash inflows of $26.7 million from Australian operations are already funding the $22.7 million cash outflow Nearmap logged in the U.S. in FY 2018 as it invested for growth.
  • Market Opportunity – Nearmap is only bringing in US$12.9 million in ACV from the U.S. and whatever the differing estimates of the size of its addressable market in the U.S. it's clear the sky is pretty much the limit for it in terms of addressable markets and growth.
  • Valuation – even after its white hot share price rise to $1.73, Nearmap is trading on an enterprise value to trailing sales ratio of around 11.8x according to my calculations ($635m / $53.6m). This is on the expensive side in my opinion, but it's actually still cheaper than many of its SaaS peers in Australia such as WiseTech Global Ltd (ASX: WTC), Pro Medicus Limited (ASX: PME) and Xero Limited (ASX: XRO), or some of the other hot U.S. SaaS businesses. Admittedly, Nearmap's business model isn't as strong as some of the aforementioned, but investors are compensated by a cheaper valuation and the fact that Nearmap is coming off a much smaller base which provides room for larger returns.
  • Management – I mentioned the head of U.S. sales before in Patrick Quigley who appears an excellent salesman, while current CEO Rob Newman has built a stronger culture than his predecessor. Newman has also managed the capital requirements of the business pretty well in my opinion.

Clearly buying Nearmap shares at today's valuation is a risky business given it just posted a heavy loss and operates in a fast-changing technological environment.

However, I wouldn't be surprised to see the shares above $3 by the end of 2020 if sales pick up steam in the U.S. and that might not be the end of the gains for investors who hang onto this business for the long term.

It's not just Nearmap that might shoot-the-lights out in the years ahead…

Motley Fool writer Tom Richardson owns shares of Nearmap Ltd., Pro Medicus Ltd., and Xero. You can find Tom on Twitter @tommyr345 The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. and Pro Medicus Ltd. The Motley Fool Australia owns shares of WiseTech Global and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Three businesspeople leap high with the CBD in the background.
Share Market News

Boom! ASX 200 blasts to new record highs

ASX 200 investors just sent the benchmark index into uncharted territory.

Read more »